Adv. Sharon Gazit, Head of our Corporate and Technology Department and Co-Chair of the Healthcare and Life Sciences Law Committee of the International Bar Association (IBA), moderated a Webinar organized by the IBA’s Healthcare and Lifescience Committee.
The webinar, held on September 29, 2020, focused on the influence of the Covid-19 pandemic on the regulatory approval paths for medicine, medical devices, diagnostics and vaccines; as well as on clinical trials around the world.
Other speakers in the webinar included Dianne Bourque, Professor Henry Cohen, Thomas Lönngren and Shohta Ueno, PhD.
For a full recording of the webinar on the IBA website:
